TAMPA, FL / ACCESS Newswire / November 20, 2025 / (“Wellgistics”) (NASDAQ:WGRX), a health information technology leader at the nexus of serialization of healthcare technology infrastructure into the ...

U.S. consumers who have had their fill of finding protein added to everything from cereal to ice cream are about to meet the ...

Eli Lilly on Friday crossed the $1 trillion market-cap threshold, becoming the first drugmaker to ever reach that milestone.

New research is shedding light on how weight-loss and diabetes medications like Ozempic, Wegovy, and Mounjaro affect not only ...

We asked doctors who prescribe GLP-1 medications to break down this trend and explain whether it’s worth it to consider ...

A growing number of people are searching for weight loss options that feel manageable in daily life. Many of the current ...

GLP-1 RAs are associated with a 62% reduction in 5-year mortality in colon cancer patients, especially those with high obesity. The study's findings remained significant after adjusting for ...

New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

The demand for weight-loss drugs like Ozempic and Zepbound is higher than ever, so much so that drugmakers Novo Nordisk and ...

By 2030, households with GLP-1 users are projected to represent 35% of all food and beverage units sold, the consumer ...

A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular ...

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) use was significantly associated with a reduced odds of five-year mortality, but this protective effect was found to be statistically significant ...